A
Adents
Enables companies to contact their customers and control the distribution channel of their products
About Adents
Adents specializes in providing advanced serialization software solutions for the pharmaceutical industry, focusing on unique product identification and traceability. The company serves pharmaceutical manufacturers and brands, helping them comply with global and regional serialization regulations, protect against counterfeiting and grey markets, and manage their distribution channels more effectively. Adents' core product, Adents Seriza, enables comprehensive serialization across all packaging levels, from individual units to pallets, ensuring each product is uniquely identifiable. The software suite is designed to be robust, versatile, and quickly deployable, allowing clients to track and trace an unlimited number of products globally. Adents collaborates with certified solution partners and industry leaders like Siemens to deliver powerful and reliable serialization solutions. The business model primarily involves selling software licenses and providing ongoing support and updates, generating revenue through subscription fees and service contracts. Adents operates in the global pharmaceutical market, addressing the critical need for compliance with serialization regulations and efficient data management.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Apr 2017 | $0 | — | Claret Capital Partners | — |
| SERIES C✓Equity / VC | Jul 2016 | $13M | $53M | Naxicap Partners · Omnes Capital · CapHorn | ↗ |
Growth signals
Latest recorded traffic for Adents is 60 monthly website visits, down 25% over the last three months. Adents's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Naxicap Partners
CapHorn
Omnes Capital
Series B and later1 investor entered at this stage
Claret Capital Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Adents on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Adents’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







